Top Markets
Coin of the day
Glow Lifetech Corp. Glow Lifetech Corp.

Glow Lifetech Corp.

GLOW
Pozycja w akcjach #34037
Glow Lifetech Corp. is a biotechnology enterprise based in North America,... Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Cena akcji
$0.03302716
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$6.36M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-8.72%
Kraj
CA
Handel Glow Lifetech Corp. (GLOW)

Kategoria

Zyski dla Glow Lifetech Corp. (GLOW)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Glow Lifetech Corp., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Glow Lifetech Corp. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$5.27B -
US
$1.95B -
NL
- -
CH
- -
KR
$3.01B -
BE